NCT07064122
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07064122
Title A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | AUS

Facility Status City State Zip Country Details
Research Site NOT_YET_RECRUITING Miami Florida 33136 United States Details
Research Site RECRUITING Tampa Florida 33612 United States Details
Research Site NOT_YET_RECRUITING Houston Texas 77030 United States Details
Research Site NOT_YET_RECRUITING Heidelberg 3084 Australia Details
Research Site RECRUITING Melbourne 3000 Australia Details
Research Site RECRUITING Shinagawa-ku 141-0022 Japan Details
Research Site RECRUITING Yoshida-gun 910-1193 Japan Details
Research Site WITHDRAWN Seoul 05505 South Korea Details
Research Site WITHDRAWN Seoul 3722 South Korea Details
Research Site RECRUITING Barcelona 08035 Spain Details
Research Site RECRUITING Madrid 28027 Spain Details
Research Site RECRUITING Madrid 28033 Spain Details
Research Site RECRUITING Pamplona 31008 Spain Details
Research Site NOT_YET_RECRUITING Salamanca 37007 Spain Details
Research Site NOT_YET_RECRUITING Valencia 46026 Spain Details
Research Site NOT_YET_RECRUITING Kaohsiung City 83301 Taiwan Details
Research Site NOT_YET_RECRUITING Tainan 70403 Taiwan Details
Research Site NOT_YET_RECRUITING Taipei 100 Taiwan Details
Research Site RECRUITING London SE5 9RS United Kingdom Details
Research Site NOT_YET_RECRUITING London W1T 7HA United Kingdom Details
Research Site RECRUITING Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field